Publication | Closed Access
O4 PROLONGED THERAPY OF HEPATITIS DELTA FOR 96 WEEKS WITH PEGYLATED-INTERFERON-α-2a PLUS TENOFOVIR OR PLACEBO DOES NOT PREVENT HDVRNA RELAPSE AFTER TREATMENT: THE HIDIT-2 STUDY
54
Citations
0
References
2014
Year
Hidit-2 StudyViral HepatitisImmunologyHepatitis BHepatitisAntiviral TherapyChronic Viral InfectionMedicine
No additional data available for this publication yet. Check back later!